India’s biopharma and biomedical industry is valued at over $58 billion. The new technology could help ensure that the country has a clean way of addressing biopharmaceutical waste.
US to impose no tariff on generic pharmaceutical goods initially, before hiking to 200%. Announcement set to impact India as US accounts for third of pharma exports from nation.
While multinational pharmaceutical companies use India to test out their new medicines, India’s researchers rarely lead the development of those therapies.
NITI Aayog's Trade Watch Quarterly report says India remains competitive in generics but lags in biologics, vaccines and advanced therapies, limiting its share of $1.3 tn global market.
India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.
Republic TV, which sees the Congress’ hand everywhere, blamed the party again—even though it’s a junior partner in the Jharkhand Mukti Morcha government led by Hemant Soren.
NSFDC beneficiaries fell from 1.18 lakh to 61,394 in a year as a Parliamentary panel flagged no fresh equity, nine board vacancies and weak state agencies.
It is reliably learnt that Airbus, which had initially offered its A400M, is likely to sit it out since its aircraft outweighs requirements with payload capacity of 37 tonnes.
It’s evident Bhagwat was watching from a distance and was worried about youth’s anger towards Modi govt. The first thing he did was to demolish any criticism of Gen Z protesters as anti-national.
COMMENTS